Add to ORKGChemoresistance is a primary cause of treatment failure in liver cancer and a common property of liver cancer stem cells. The thesis developed three different strategies to reverse chemoresistance in liver cancer stem cells, providing the potential for improving the treatment efficacy of liver cancer
PhD ThesisNon-alcoholic fatty liver disease (NAFLD) has become the commonest form of chronic liver d...
The development of chemoresistance and inability in elimination of cancer stem cells are among the k...
As a researcher and advocate of individualized treatment, after decades of stagnation in the develop...
This thesis successfully developed a novel strategy using chemical antibodies for targeting ca...
Rhys Gillman researched liver and oral cancers. He studied a previously uncharacterised gene and fou...
It is well known that cancer stem cells (CSCs) play a pivotal role in tumor metastasis, recurrence, ...
AbstractHepatocellular carcinoma (HCC) is a major primary liver malignancy in adults. Despite the pr...
Liver cancer is an often fatal malignant tumor with a high recurrence rate and chemoresistance. The ...
The aim of this project was to investigate pharmacological methods of overcoming resistance in cance...
Background Liver cancer is the second most common cause of cancer-related death. Every type of tumou...
Chemo-resistant and tumor recurrence are the major hurdle to overcome the cancer patients. Especiall...
Current approaches to selecting new chemotherapies are inadequate. In vitro tissue culture models ig...
Although cancer chemotlherapy has been one of the major medical advances in the last few decades, ca...
Small cell lung cancer (SCLC) is an extremely aggressive, pulmonary malignancy linked to lifetime sm...
Drug resistance in cancer cells is a serious complication that is always continuously evolving. Rath...
PhD ThesisNon-alcoholic fatty liver disease (NAFLD) has become the commonest form of chronic liver d...
The development of chemoresistance and inability in elimination of cancer stem cells are among the k...
As a researcher and advocate of individualized treatment, after decades of stagnation in the develop...
This thesis successfully developed a novel strategy using chemical antibodies for targeting ca...
Rhys Gillman researched liver and oral cancers. He studied a previously uncharacterised gene and fou...
It is well known that cancer stem cells (CSCs) play a pivotal role in tumor metastasis, recurrence, ...
AbstractHepatocellular carcinoma (HCC) is a major primary liver malignancy in adults. Despite the pr...
Liver cancer is an often fatal malignant tumor with a high recurrence rate and chemoresistance. The ...
The aim of this project was to investigate pharmacological methods of overcoming resistance in cance...
Background Liver cancer is the second most common cause of cancer-related death. Every type of tumou...
Chemo-resistant and tumor recurrence are the major hurdle to overcome the cancer patients. Especiall...
Current approaches to selecting new chemotherapies are inadequate. In vitro tissue culture models ig...
Although cancer chemotlherapy has been one of the major medical advances in the last few decades, ca...
Small cell lung cancer (SCLC) is an extremely aggressive, pulmonary malignancy linked to lifetime sm...
Drug resistance in cancer cells is a serious complication that is always continuously evolving. Rath...
PhD ThesisNon-alcoholic fatty liver disease (NAFLD) has become the commonest form of chronic liver d...
The development of chemoresistance and inability in elimination of cancer stem cells are among the k...
As a researcher and advocate of individualized treatment, after decades of stagnation in the develop...